http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6217655-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f97f0fa258a008bf056ad04b7f380dda |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06 |
filingDate | 1985-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ba33f0298974eb3a92941d4b1425717 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd2eaa3885588c323850cc3c02746bda |
publicationDate | 1987-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-S6217655-A |
titleOfInvention | Method and apparatus for analyzing lidocaine in blood |
abstract | PURPOSE: To facilitate automation and to shorten the analytical time of a specimen, by directly injecting serum in a high performance liquid chromatography to perform the separation and quantification of lidocaine in blood. n CONSTITUTION: An analytical apparatus 1 is equipped with the flow line 7 of a phosphate buffer solution as a first mobile phase, the flow line 8 of a second mobile phase 4, pretreatment column 5 comprising tetramethylolmethane triacrylate resin, the flow line 13 for the pretreatment column and the analytical flow line 6 to a separation column 10 and these elements are connected so as to be capable of being changed over by a six-way valve 6. Serum being a specimen is introduced into the column 5 comprising a polymethylolalkane polyacrylate resin by using the buffer solution 2 with pH5W12 containing a poplar org. solvent as the first mobile phase to together trap lidocaine and a protein component. Next, lidocaine is eluted by using a buffer solution with pH5 or less containing a polar org. solvent as the second mobile phase 4 and the eluate is subjected to a high performance liquid chromatography to perform the analysis of lidocaine. n COPYRIGHT: (C)1987,JPO&Japio |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04266783-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106248819-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01250858-A |
priorityDate | 1985-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.